Your browser doesn't support javascript.
loading
Targeting PDGF-mediated recruitment of pericytes blocks vascular mimicry and tumor growth.
Thijssen, Victor Ljl; Paulis, Yvette Wj; Nowak-Sliwinska, Patrycja; Deumelandt, Katrin L; Hosaka, Kayoko; Soetekouw, Patricia Mmb; Cimpean, Anca M; Raica, Marius; Pauwels, Patrick; van den Oord, Joost J; Tjan-Heijnen, Vivianne Cg; Hendrix, Mary J; Heldin, Carl-Henrik; Cao, Yihai; Griffioen, Arjan W.
Afiliación
  • Thijssen VL; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Paulis YW; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Nowak-Sliwinska P; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Deumelandt KL; Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Hosaka K; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Soetekouw PM; School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
  • Cimpean AM; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Raica M; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
  • Pauwels P; Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • van den Oord JJ; Department of Microscopic Morphology, Histology, Angiogenesis Research Center, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
  • Tjan-Heijnen VC; Department of Microscopic Morphology, Histology, Angiogenesis Research Center, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.
  • Hendrix MJ; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.
  • Heldin CH; Laboratory of Translational Cell and Tissue Research, University of Leuven, Leuven, Belgium.
  • Cao Y; Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Griffioen AW; Department of Biology, Shepherd University, Shepherdstown University, WV, USA.
J Pathol ; 246(4): 447-458, 2018 12.
Article en En | MEDLINE | ID: mdl-30101525
ABSTRACT
Aggressive tumor cells can adopt an endothelial cell-like phenotype and contribute to the formation of a tumor vasculature, independent of tumor angiogenesis. This adoptive mechanism is referred to as vascular mimicry and it is associated with poor survival in cancer patients. To what extent tumor cells capable of vascular mimicry phenocopy the angiogenic cascade is still poorly explored. Here, we identify pericytes as important players in vascular mimicry. We found that pericytes are recruited by vascular mimicry-positive tumor cells in order to facilitate sprouting and to provide structural support of the vascular-like networks. The pericyte recruitment is mediated through platelet-derived growth factor (PDGF)-B. Consequently, preventing PDGF-B signaling by blocking the PDGF receptors with either the small tyrosine kinase inhibitor imatinib or blocking antibodies inhibits vascular mimicry and tumor growth. Collectively, the current study identifies an important role for pericytes in the formation of vascular-like structures by tumor cells. Moreover, the mechanism that controls the pericyte recruitment provides therapeutic opportunities for patients with aggressive vascular mimicry-positive cancer types. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Melanoma Experimental / Factor de Crecimiento Derivado de Plaquetas / Pericitos / Inhibidores de Proteínas Quinasas / Proliferación Celular / Mesilato de Imatinib / Mimetismo Biológico / Antineoplásicos Inmunológicos / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Pathol Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Melanoma Experimental / Factor de Crecimiento Derivado de Plaquetas / Pericitos / Inhibidores de Proteínas Quinasas / Proliferación Celular / Mesilato de Imatinib / Mimetismo Biológico / Antineoplásicos Inmunológicos / Neovascularización Patológica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: J Pathol Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos